Asthma and chronic obstructive pulmonary disorder (COPD) are well known chronic inflammatory respiratory disease affecting millions of people worldwide. Asthma originates in childhood, is associated with allergies and related toeosinophils, whereas, COPD occurs in adults who smoke, due to involvement of neutrophils. The current allopathic system of medicine aim to alleviate symptoms rather than cure, basically these treatments includes anti-inflammatory therapy, corticosteroids, and bronchodilators. Over use of some therapies can lead to adverse effects among patients, such as pneumonia and cardiac comorbidities. Nowadays, the interest of people diverts toward the area of phytomedicine. Phytomedicine is a plant-based traditional medical practice which provides an alternative source or as an add-on therapy to the existing one. Some herbs, such as Khella and Lobelia are widely used as vasodilators and bronchodilators having no side effects. This review focuses on recent human clinical trials using plant-based medicines for treatment of asthma and COPD.
INTRODUCTION
A sthma and chronic obstructive pulmonary disorder (COPD) are characterized as different diseases with unique features and mechanisms. Asthma is an allergic disease that can develop during childhood, can also be diagnosed in adults. It is characterized by airway hyper responsiveness that leads to reversible airway obstruction. COPD is a chronic respiratory disease that is linked to smoking tobacco, usually, presents in 40 years of age, and is characterized by progressive and irreversible airway obstruction. [1, 2] It is characterized by symptoms such as respiratory problems, including wheezing, shortness of breath, chest tightness, and coughing. [3] Asthma and COPD are common inflammatory obstructive lung diseases which affect many millions of people worldwide. [4, 5] While in basic and clinical research has led to important advances, both conditions are increasing day-byday. Although mortality rates for asthma are relatively low, representing only 1%. [6] Current treatment for allergic asthma include steroidal anti-inflammatory compounds, leukotriene antagonists, bronchodilators, and recent anti-IgE antibody. These drugs are still with certain shortcoming such as side effects, effectiveness, and cost. [7] Thus, there is a need to consider other therapeutic options including phytomedicine.
Phytomedicine is defined as a plant-based traditional medical practice that uses plant materials in modalities considered both preventive and therapeutic. [8] The word "Phyto" derives from the Greek means plant; hence, it means plant-based medicine. Phytomedicine is rooted in scientific research. [9] Current treatments such as that of steroids, bronchodilators, and anti-IgE antibodies have shortcoming side effects and cost-effective. Therefore, complementary methods such as Chinese, Japanese, and Indian herbal medication have been very much improved. However, our study focuses only on Indian and Chinese herbal treatments available for treating asthma and COPD. [10] EPIDEMIOLOGY COPD COPD is the fourth leading cause of death in the United State of America (USA). In 2001, the World Health Organization reports that COPD was the fifth cause of death in high-income countries and the sixth leading cause of death in middleincome countries. COPD usually presents in middle age, is slowly progressive and is associated with the history of cigarette smoking in 75-90% of patients. [14] Patients usually present with a chronic productive cough is not a frequent finding. Clinical symptoms are slowly progressive, and airflow limitation is only partially reversible after tobacco cessation and bronchodilator use. T lymphocytes, with macrophages and neutrophils, are the predominant inflammatory cell types.
Recent studies concluded that women as compared with men shows a higher incidence of asthma-COPD overlap and also that all-cause mortality is greater in younger participants and women with overlap of asthma-COPD than participants suffering from asthma and COPD alone.
Asthma
In 2005, an estimated 22.2 million Americans had asthma: 6.5 million children and 15.7 million adults. The public health impact of asthma is significant. In 2003, asthma accounted for 1.4 deaths/100,000 persons in the USA. [15] According to the National Center for Health Statistics, in 2003, children between the age of 5 and 17 years with a history of at least one asthma attack in the previous year accounted for 12.6 million missed school days, and adults with a history of at least one asthma attack in the previous year account for 10.1 million missed workdays. Table 1 : Summarization of similarities and differences between COPD and asthma [11] [12] [13] 
Symptoms
Asthma COPD 
PATHOPHYSIOLOGY
Asthma and COPD are diseases that cause chronic inflammation of the airways but have distinct characteristics. In asthma, mast cells, eosinophil, and cluster of differentiation 4 (CD4), T-lymphocytes represent the predominant cell types in the inflammatory process. In contrast, COPD demonstrates a greater number of neutrophils, macrophages, and CD8 T lymphocytes. [16] [17] [18] Pathophysiology for asthma and COPD shown in Figure 1 .
Asthmatic patients have airway obstruction which is characterized by bronchoconstriction through the activation of the smooth muscle and membrane thickening. These alterations are positively correlated with the frequency of asthma attacks and bronchial hyper responsiveness. [19, 20] COPD patients exhibit a reduced airway caliber, which is associated with cell damage is induced by external toxic agents, especially cigarette smoke, through reactive oxygen species. [21, 22] The presence of goblet cells (mucous metaplasia) in the small airways and mucous hypersecretions results from the process of airway narrowing. [23, 24] Despite the prevalence of inflammation in COPD, which occurs because of the presence of neutrophils and macrophages, several studies have demonstrated the presence of eosinophilic inflammation both in stable patients and in patients with acute exacerbations of the disease. [25] In exacerbations of COPD and asthma the pattern of inflammation is similar. During exacerbations of asthma triggered by viruses, there can be increases in the number of neutrophils in addition to the proliferation of eosinophils. Moreover, in COPD exacerbations, there may be an increase in eosinophil numbers. [26] This helps explain the prescribing of corticosteroids to COPD patients to manage an acute exacerbation or frequent exacerbations. [27] In asthma, airway obstruction results from constriction of bronchial smooth muscle, airway hyperreactivity to allergens, and inflammation accompanied by increased eosinophils and activated T-cells. In COPD, airway smooth muscle is not usually constricted and obstruction is associated mainly with mucus hypersecretion and mucosal infiltration by inflammatory cells, leading to cellular damage, and the loss of alveolar structure and structural changes associated with COPD interfere with oxygenation and pulmonary circulation.
TEST AND DIAGNOSIS
Lung (pulmonary) function tests to determine how much air moves in and out as you breathe. These tests may include:
• Lung function test: In asthma, the finding of airflow obstruction that is characterized by a decrease of VEF1/ FVC with a disorder reversal after the administration of a bronchodilator is the mainstay in the diagnostic confirmation of the disease. However, many patients may present with a reversal after the use of a bronchodilator without exhibits normalization in pulmonary function tests, thus indicating signs of bronchial remodeling. Moreover, clinically stable patients may present with normal spirometry but a positive bronchial provocation test. The use of the FEV1/FVC ratio remains the most widely accepted parameter for diagnostic confirmation.
In COPD, a post-bronchodilator FEV1<85% that is associated with a FEV1/FVC ratio <70% confirms the obstructive disorder, which is characterized by a lack of complete reversibility of airflow. However, a significant response to the bronchodilator does not exclude a COPD diagnosis. [28] • Spirometry: This test estimates the narrowing of your bronchial tubes by checking how much air you can exhale after a deep breath and how fast you can breathe out. • Peak flow: A peak flow meter is a simple device that measures how hard you can breathe out. Lower than usual peak flow readings are a sign your lungs may not be working as well and that your asthma may be getting worse. Your doctor will give you instructions on how to track and deal with low peak flow readings. [29] Lung function tests often are done before and after taking a medication called a bronchodilator, such as albuterol, to open your airways. If your lung function improves with the use of a bronchodilator, it is likely you have asthma.
Additional Tests
Other tests to diagnose asthma and COPD include: asthma. In these tests, your doctor measures your airway obstruction before and after you perform vigorous physical activity or take several breaths of cold air. [30] CURRENT TREATMENT Current treatment for asthma and COPD include the pharmacological and non-pharmacological managements in pharmacological management drugssteroidal antiinflammatory compounds, leukotriene antagonists, bronchodilators, and recent anti-IgE antibody. These drugs are still with certainshortcoming such as side effects, effectiveness, and cost mentioned in the Table 2 .
Non-Pharmacological Management of Asthma and COPD [33] Non-pharmacological management of asthma and COPD includes some life modification, surgical options and other therapies as listed below. 
PHYTOMEDICINE IN THE TREATMENT OF ASTHMA AND COPD
In recent years, natural products have received great attention for disease prevention because of the health benefits and noticeable lack of toxicity and side effects. [34] Many dietary plant, fruits, vegetables, medicinal plants, and herbs contain various phytochemical constituents, such as alkaloids, nitrogencompounds, and vitamins. [35] Phytomedicine is known as the branch of plant-based traditional medical practice that uses various plant materials considered both preventive and therapeutic. Herbs usually naturally contain many important chemicals and thus medicines derived from such sources can have multiple health benefits when administered to patients. Because of the presence of many active compounds in phytomedicines, they are an ideal candidate for treating conditions with a variety of symptoms such as inflammatory diseases which basically affect multiple systems.
Historically, particularly in Chinese and other Asian cultures, plant-based medicines have been used to treat and prevent lung disease, and to this day remain a major therapeutic option; thus, the idea of using plant-derived medicines for treatment of asthma and COPD is not a latest concept. However, despite the antimucus secreting properties and smooth muscle relaxant effect, atropine was found to be ineffective in improving the symptoms of asthma in clinical trials. [36] Atropine remains a treatment of cardiac bradyarrhythmias, and has been used successfully in the treatment of conditions such as amblyopia, also known as lazy eye. [8] Various phytomedicines for treating asthma are available. These are Oregano, GinkoBiloba, Ginger, Garlic, Slippery Elm, Liquorice, Turmeric, Lemongrass, Stinging Nettle, and Bishop's Weed.
Oregano
Contains carvacrol, flavonoids, and terpenes that work as lung-cleansing elements.
Ginkgo Biloba
Contains antihistamine properties that help treat asthma.
Ginger
Helps reduce airway inflammation and inhibit airway contraction. Garlic is a popular medicinal herb helpsin clearing congestion in the lungs. In addition, its antibiotic and antiviral properties help boost immunity and fight infections that can trigger asthma.
Slippery Elm
Is another effective herb having anti-inflammatory properties that helps thin the mucus that clogs the airways.
Liquorice
Has a systemic anti-inflammatory effect on the lungs, which helps reduce inflammation of the bronchial tubes, calm the airways, and restore normal breathing. In addition, it has immune-stimulant properties.
Turmeric
Is a powerful herb to prevent asthma attacks and other allergies. It contains the active ingredient curcumin, a powerful antioxidant and anti-inflammatory compound that helps fight asthma symptoms.
Lemongrass
It is widely used in traditional medicines for treating asthma, coughs, and other respiratory disorders. It also has antibacterial and antifungal properties that help reduce inflammation and fight infections. In addition, it has Vitamin C that boosts your immune system.
Stinging Nettle
Is an excellent treatment for allergy-related asthma. This herb contains natural antihistamines and anti-inflammatory properties that help open up constricted bronchial and nasal passages to relieve asthma symptoms. In addition, it is rich in butyric acid, which helps maintain a healthy immune system and metabolism.
Bishop's Weed
Commonly known as carom seeds or ajwain, is also useful for treating asthma. It exerts a strong antispasmodic effect on the inflamed bronchioles, which in turn relieves asthma symptoms. [8] The various remedies for COPD are Omega 3 having beneficial anti-inflammatory effects, Essential amino acids, which are basically building block of protein improves cognitive function, quality of life, and muscle strength, especially in underweight people, antioxidant vitamins such as Vitamin A, C, and E, Essential oils such as Myrtol, Eucalyptus oil, and Orange oil that can reduce airway inflammation, zatariamultiflora.
List of some other phytomedicines with their plant origin [37] : 
PLANT-BASED THERAPIES FOR ASTHMA

Anti-asthma Herbal Medicine Intervention (ASHMI)
Plant-based medicine a number of plant-based medicines have shown promising results in studies of asthma, such as ASHMI. ASHMI is a combination of three extracts; Ling Zhi from Ganodermalucidem, Ku Shen from Sophoraflavescentis and Gan Cao from Glycyrhhiza, which has shown potential for the treatment of asthma in both in vitro and in vivo. A native tree of Indonesia and India which used in traditional remedies not only for the treatment of asthma but for pain, fever, and headaches. [37] ASHMI had a beneficial effect on both TH1 and TH2 cytokine levels and absolutely no adverse effects on adrenal function in the study participants.
A. mollucanna
More recently, the antinociceptive effects of A. molluccana and its mechanical antihypersensitivity activities have been investigated. A. mollucanna has also been found to possess antiviral and antimicrobial properties showing how the existence of multiple active compounds in plant extracts can have several benefits to patients. Due to this historical link between A. mullucanna and antinociceptive and anti-inflammatory therapies, A. mullucanna extracts have been used to produce analgesic and anti-inflammatory phytomedicines. There is a possibility for the active compounds of A. mullucanna to be adapted to produce a phytomedicine for asthma and its related symptoms. [38] The results were very positive.
Nigella sativa
A plant native to Southeast Asia is known for its relaxing effect on smooth muscle tissue. In addition, Boskabady and colleagues have demonstrated that extracts and oils from N.sativa have inhibitory effects on histamine (H 1 ) receptors, stimulatory effects on β-adrenergic receptors and antitussive effects. [35] To translate these promising in vitro findings Boskabady and colleagues set out to investigate the effect of boiled N. sativa extract on lung function in asthmatic patients. [36] In this study, they compared the bronchodilatory effects of N. sativa with those of theophylline in 16 asthmatics. They found that N. sativa did induce bronchodilation within 35 min of administration, but the magnitude was significantly less than observed with theophylline and that both agents were significantly less effective than beta-2 agonist salbutamol. Nonetheless, they concluded that N. sativa has relatively potent bronchodilatory effects but when given orally it is less effective than conventional bronchodilators. It is possible that the bronchodilatory effects of compounds such as N. sativa could be enhanced if formulated as inhaled therapy with delivery of the active compounds directly to the airway. [8] Tianjiu therapy in Sanfu days Zhu et al. studied the effect of Tianjiu therapy in Snafu days for treatment of asthmatic children. Tianjiu therapy in Sanfu days is a classic prevention treatment for asthma [37] Sanfu Days means the three hottest days in a year, which are calculated by ancient calendar. The results suggested that Tianjiu therapy could decrease the asthma attack.
PLANT-BASED THERAPIES FOR COPD
Evidence from three double-blind placebo-controlled studies enrolling a total of 49 individuals suggests that the supplement L-carnitine can improve exercise tolerance in COPD, presumably by improving muscular efficiency in the lungs and other muscles.
Eucalyptus is a standard ingredient in cough drops and in oils sometimes added to humidifiers. A combination essential oil therapy containing cineole from eucalyptus, d-limonene from citrus fruit, and alpha-pinene from pine has been studied for a variety of respiratory conditions. Because these oils are all in a chemical family called monoterpenes, the treatment is called essential oil monoterpenes. A 3-month, double-blind trial of 246 individuals with chronic bronchitis found that oral treatment with essential oil monoterpenes helped prevent acute flare-ups 27 of chronic bronchitis. A previous double-blind study, too small to provide reliable results, hints that oral use of 26 essential oil monoterpenes can enhance the effects of antibiotics for acute flareups once they do occur. It is 28 thought that essential oil monoterpenes work by improving the lungs' ability to clear secretions.
A mixture of extracts from echinacea, wild indigo, and white cedar has shown promise for treating a variety of respiratory infections. A well-designed double-blind, placebo-controlled trial of 53 people tested its benefits in acute exacerbations of chronic bronchitis. [39] All participants in this trial received standard antibiotic therapy. The results showed that people receiving the herbal medication experienced more rapid improvements in lung function than those given placebo.
In one poorly designed and reported study, use of an Ayurvedic herbal combination appeared to offer some 36 benefit. It has been suggested that the sports supplement creatine might improve muscle strength in people with COPD, but results from small double-blind studies have been inconsistent. Slight evidence from a small open trial suggests that coenzyme Q improves lung function in individuals with COPD. [40, 41] The herbs ivy leaf and plantain have been suggested for chronic bronchitis, but there is no meaningful evidence that they actually help. [42] One study failed to find pomegranate juice helpful for COPD.
Qigong is an ancient form of Traditional Chinese Medicine consisting of deep breathing accompanied by slow, rhythmic movements. It is intended to promote the healthy flow of "qi" (or vital "energy") within the body. In a randomized trial involving 206 patients with COPD, Qigong appeared to improve respiratory function and activity tolerance. [43] In another trial, 80 people with COPD were randomized to receive Qigong or conventional rehabilitation for 6 months. At the end of the trial, there were no significant differences between the two groups. [44] Cineole (Eucalyptus, Myrtaceae) has positive effects on the beat frequency of the cilia and bronchodilation, it may show positive influence on the exacerbations of COPD and lung function tests. Patients who received 200 mg of cineole tablets three times a day had a reduction of exacerbations such as dyspnea and improvements of lung function and health status. [44] • Astragalus (Milk Vetch Root, Huang Qi, Leguminosae) and Codonopsis pilosula are used for their immune modulatory and anti-inflammatory effects. The effects of Astragalus polysaccharides (APS) and C. pilosula polysaccharides on alveolar macrophage (AM) phagocytosis and inflammation in COPD. [8] • Pseudolysimachion rotundum var. subintegrum (Speedwell, Plantaginaceae) is used as a traditional herbal medicine for treatings bronchitis inflammation, autophagy has been recently reported to contribute to COPD.
CONCLUSION
Although COPD and asthma are two different forms of chronic pulmonary disease, there is considerable overlap in presentation and management. Both conditions are caused by an interaction between intrinsic, genetic factors, and environmental exposures. Treatment of these diseases is similar in that they can both be managed with pharmacological and non-pharmacological strategies focused on treating bronchoconstriction and airway inflammation. The current treatment shows the adverse effect related to their high dose will surely hamper their prestige in the upcoming years. To conclude, we can say that phytomedicine field also needs to be explored because there is a lack of proper evidence, but it has huge potential as lesser side effects are associated than conventional treatment. Thus, in coming era the phytomedicines will outshine.
